These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 8645180)
21. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets. Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827 [TBL] [Abstract][Full Text] [Related]
22. Thrombin-induced conversion of fibrinogen to fibrin results in rapid platelet trapping which is not dependent on platelet activation or GPIb. Jarvis GE; Atkinson BT; Frampton J; Watson SP Br J Pharmacol; 2003 Feb; 138(4):574-83. PubMed ID: 12598411 [TBL] [Abstract][Full Text] [Related]
23. A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets. Rasmussen UB; Gachet C; Schlesinger Y; Hanau D; Ohlmann P; Van Obberghen-Schilling E; Pouysségur J; Cazenave JP; Pavirani A J Biol Chem; 1993 Jul; 268(19):14322-8. PubMed ID: 8390990 [TBL] [Abstract][Full Text] [Related]
24. Contributions of glycoprotein Ib and the seven transmembrane domain receptor to increases in platelet cytoplasmic [Ca2+] induced by alpha-thrombin. Greco NJ; Tandon NN; Jones GD; Kornhauser R; Jackson B; Yamamoto N; Tanoue K; Jamieson GA Biochemistry; 1996 Jan; 35(3):906-14. PubMed ID: 8547272 [TBL] [Abstract][Full Text] [Related]
25. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action. Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791 [TBL] [Abstract][Full Text] [Related]
26. Platelet aggregation monitored in a 96 well microplate reader is useful for evaluation of platelet agonists and antagonists. Bednar B; Condra C; Gould RJ; Connolly TM Thromb Res; 1995 Mar; 77(5):453-63. PubMed ID: 7778060 [TBL] [Abstract][Full Text] [Related]
27. Platelet activation by Protease I of Porphyromonas gingivalis W83. Curtis MA; Macey M; Slaney JM; Howells GL FEMS Microbiol Lett; 1993 Jun; 110(2):167-73. PubMed ID: 8394260 [TBL] [Abstract][Full Text] [Related]
28. Interaction of the protein C activation peptide with platelets. Martínez-Cruz R; Canseco Mdel S; Lopez-Martínez J; Cruz PA; Pérez-Campos E; Cruz MM; Alva FC; Majluf-Cruz A; Zenteno E; Ruiz-Argüelles A Prep Biochem Biotechnol; 2007; 37(2):139-47. PubMed ID: 17454824 [TBL] [Abstract][Full Text] [Related]
29. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin. McNicol A; Robson CA J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395 [TBL] [Abstract][Full Text] [Related]
30. Ni2+ impairs thrombin-induced signal transduction by acting on the agonist and/or receptor in human platelets. Azula FJ; Alonso R; Marino A; Trueba M; Macarulla JM Am J Physiol; 1993 Dec; 265(6 Pt 1):C1681-8. PubMed ID: 8279529 [TBL] [Abstract][Full Text] [Related]
31. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379 [TBL] [Abstract][Full Text] [Related]
32. Defective thrombin-induced calcium changes and aggregation of Bernard-Soulier platelets are not associated with deficient moderate-affinity receptors. McNicol A; Sutherland M; Zou R; Drouin J Arterioscler Thromb Vasc Biol; 1996 May; 16(5):628-32. PubMed ID: 8963719 [TBL] [Abstract][Full Text] [Related]
33. Thrombin-induced platelet activation and its inhibition by anticoagulants with different modes of action. Nylander S; Mattsson C Blood Coagul Fibrinolysis; 2003 Feb; 14(2):159-67. PubMed ID: 12632026 [TBL] [Abstract][Full Text] [Related]
34. Interaction of viper venom serine peptidases with thrombin receptors on human platelets. Santos BF; Serrano SM; Kuliopulos A; Niewiarowski S FEBS Lett; 2000 Jul; 477(3):199-202. PubMed ID: 10908720 [TBL] [Abstract][Full Text] [Related]
35. Thrombin- and cathepsin G-induced platelet aggregation: effect of protein kinase C inhibitors. Puri RN; Colman RW Anal Biochem; 1993 Apr; 210(1):50-7. PubMed ID: 7683848 [TBL] [Abstract][Full Text] [Related]
36. Cerastotin, a serine protease from Cerastes cerastes venom, with platelet-aggregating and agglutinating properties. Marrakchi N; Barbouche R; Guermazi S; Karoui H; Bon C; El Ayeb M Eur J Biochem; 1997 Jul; 247(1):121-8. PubMed ID: 9249017 [TBL] [Abstract][Full Text] [Related]
37. Cathepsin G and thrombin: evidence for two different platelet receptors. Selak MA Biochem J; 1994 Jan; 297 ( Pt 2)(Pt 2):269-75. PubMed ID: 8297330 [TBL] [Abstract][Full Text] [Related]
38. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators. Lau LF; Pumiglia K; Côté YP; Feinstein MB Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841 [TBL] [Abstract][Full Text] [Related]
39. Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets. Navarro-Núñez L; Rivera J; Guerrero JA; Martínez C; Vicente V; Lozano ML Br J Pharmacol; 2009 Nov; 158(6):1548-56. PubMed ID: 19814731 [TBL] [Abstract][Full Text] [Related]
40. Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin. Sower LE; Froelich CJ; Allegretto N; Rose PM; Hanna WD; Klimpel GR J Immunol; 1996 Apr; 156(7):2585-90. PubMed ID: 8786323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]